Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company Jul 22, 2021 09:15AM
Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors Jul 7, 2021 07:00AM
Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer Jun 17, 2021 07:00AM
Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement Jun 10, 2021 05:12PM
AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes May 25, 2021 07:00AM


May 24, 2021 07:00AM Sema4 to Participate in Upcoming Investor Conferences
May 6, 2021 05:31PM Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger
Apr 19, 2021 07:00AM NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights